Gossamer Bio Q1 EPS $(0.19) Misses $(0.18) Estimate
Portfolio Pulse from Benzinga Newsdesk
Gossamer Bio reported Q1 EPS of $(0.19), missing the consensus estimate of $(0.18) by 5.56%. However, this represents a 63.46% improvement over the previous year's Q1 losses of $(0.52) per share.
May 07, 2024 | 8:48 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Gossamer Bio's Q1 earnings missed estimates slightly but showed a significant year-over-year improvement.
While Gossamer Bio missed the consensus estimate, the substantial improvement over last year's losses may be viewed positively by investors. The slight miss may not heavily impact the stock price in the short term, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100